Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Investing > J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target

Investing

J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target

Published by Wanda Rich

Posted on July 21, 2021

Featured image for article about Investing

More from Investing

Explore more articles in the Investing category

How One Investor Learned to Find Value Through a Wider Lens

Freedom Holding Corp’s Global Rise: Why Institutional Investors Are Betting Big

Pro Visionary Helps Australians Strengthen Their Financial Resilience Through Licensed Wealth Strategies

How ZenInvestor Is Breaking Down Barriers to Financial Literacy and Empowering Everyday Investors Nationwide

Edward L. Shugrue III on Returning to the Office: A Cultural Shift and Investment Opportunity

How Private Capital Can Build Public Good

Private Equity Has a Major Speed and Capacity Problem

Navigating AI Investing Tools: Wealth Management Disruption Ahead

MTF Trading Explained: What It Is, How It Works, and Key Benefits

Private Equity Has Trust Issues With AI

Merifund Capital Management on FTSE 100 Gains

Sycamine Capital Management sets outlook on Japan equities

View All Investing Posts